NO20025983L - Smertestillende og antiinflammatoriske sammensetninger som inneholder COX-2hemmere - Google Patents

Smertestillende og antiinflammatoriske sammensetninger som inneholder COX-2hemmere

Info

Publication number: NO20025983L
Authority: NO; Norway
Prior art keywords: painkillers; inhibitors; compositions containing; inflammatory compositions; containing cox
Prior art date: 2000-06-13

Application number

NO20025983A

Other languages

English (en)

Other versions

NO331092B1 (no

NO20025983D0 (no

Inventor

Stephen Allen Cooper

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-13

Filing date

2002-12-12

Publication date

2003-02-10

2002-12-12 Application filed by Wyeth Corp filed Critical Wyeth Corp

2002-12-12 Publication of NO20025983D0 publication Critical patent/NO20025983D0/no

2003-02-10 Publication of NO20025983L publication Critical patent/NO20025983L/no

2011-10-03 Publication of NO331092B1 publication Critical patent/NO331092B1/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20025983A 2000-06-13 2002-12-12 Sammensetning bestaende av celecoxib og ibuprofen. NO331092B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21130700P	2000-06-13	2000-06-13
PCT/US2001/018990 WO2001095898A1 (en)	2000-06-13	2001-06-13	Analgesic and anti-inflammatory compositions containing cox-2 inhibitors

Publications (3)

Publication Number	Publication Date
NO20025983D0 NO20025983D0 (no)	2002-12-12
NO20025983L true NO20025983L (no)	2003-02-10
NO331092B1 NO331092B1 (no)	2011-10-03

Family

ID=22786362

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20025983A NO331092B1 (no)	2000-06-13	2002-12-12	Sammensetning bestaende av celecoxib og ibuprofen.

Country Status (22)

Country	Link
US (2)	US6924303B2 (no)
EP (1)	EP1296665B1 (no)
JP (1)	JP5579958B2 (no)
KR (1)	KR20030019422A (no)
CN (1)	CN100588395C (no)
AT (1)	ATE511844T1 (no)
AU (2)	AU6837701A (no)
BR (1)	BR0111767A (no)
CA (1)	CA2411960C (no)
DK (1)	DK1296665T3 (no)
EA (2)	EA200802070A1 (no)
ES (1)	ES2365387T3 (no)
HU (1)	HU229440B1 (no)
IL (2)	IL153303A0 (no)
MX (1)	MXPA02012344A (no)
NO (1)	NO331092B1 (no)
NZ (1)	NZ522957A (no)
PL (1)	PL206268B1 (no)
PT (1)	PT1296665E (no)
RU (1)	RU2003100874A (no)
WO (1)	WO2001095898A1 (no)
ZA (1)	ZA200209944B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL153303A0 (en)	2000-06-13	2003-07-06	Wyeth Corp	Analgesic and anti-inflammatory compositions conaining cox-2 inhibitors
SI1478366T1 (sl) *	2002-02-19	2009-06-30	Adcock Ingram Ltd	Farmacevtske kombinacije meloksikama, kodein fosfata in paracetamola
US20040156931A1 (en) *	2002-12-18	2004-08-12	Algorx	Administration of capsaicinoids
TW200600086A (en) *	2004-06-05	2006-01-01	Astrazeneca Ab	Chemical compound
FR2881049B1 (fr) *	2005-01-24	2008-12-26	Vetoquinol Sa Sa	Medicament destine a etre administre par voie orale comprenant un inhibiteur de la cyclo-oxygenase-2, et son procede de preparation
US20060281775A1 (en)	2005-06-14	2006-12-14	Applied Pharmacy Services, Inc.	Two-component pharmaceutical composition for the treatment of pain
ES2651444T3 (es)	2006-10-20	2018-01-26	Johnson & Johnson Consumer Inc.	Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor
TR200904862A1 (tr) *	2009-05-29	2010-12-21	Sanovel İlaç San. Ve Ti̇c. A.Ş.	Sukraloz formülasyonu ve üretim prosesi
AU2017275844A1 (en) *	2016-05-27	2019-01-17	Dr. Reddy's Laboratories Ltd.	Oral composition of celecoxib for treatment of pain

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5331000A (en) *	1992-03-09	1994-07-19	Sepracor Inc.	Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
US5474995A (en) *	1993-06-24	1995-12-12	Merck Frosst Canada, Inc.	Phenyl heterocycles as cox-2 inhibitors
ES2141916T3 (es) *	1993-11-30	2000-04-01	Searle & Co	Pirazolil-bencenosulfonamidas sustituidas para el tratamiento de la inflamacion.
CN1140267C (zh)	1996-05-17	2004-03-03	麦克公司	治疗环加氧酶-2介导的疾病的每天一次的组合物
IL127441A (en)	1996-07-18	2003-02-12	Merck Frosst Canada Inc	Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors
US6160020A (en) *	1996-12-20	2000-12-12	Mcneill-Ppc, Inc.	Alkali metal and alkaline-earth metal salts of acetaminophen
RU2182016C2 (ru) *	1997-03-20	2002-05-10	Панацея Биотек Лтд.	Спазмолитическая композиция, способ получения спазмолитической композиции
EP0868915A1 (en)	1997-04-02	1998-10-07	Panacea Biotec Limited	An anti-spasmodic and antiinflammatory composition containing a NSAID, pentifenone and fenpiverinium
DZ2479A1 (fr)	1997-05-05	2003-02-01	Pfizer	Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
RS49982B (sr) *	1997-09-17	2008-09-29	Euro-Celtique S.A.,	Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
FR2770131A1 (fr) *	1997-10-27	1999-04-30	Union Pharma Scient Appl	Nouvelle association pharmaceutique a activite analgesique
DZ3265A1 (fr)	1999-04-14	2000-10-19	Pacific Corp	Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
US6524623B1 (en) *	1999-11-12	2003-02-25	Milton Hodosh	Therapeutic compositions and methods of use thereof
SK9032002A3 (en) *	1999-12-22	2003-03-04	Pharmacia Corp	Dual-release compositions of a cyclooxygenase-2 inhibitor
US6306842B1 (en) *	2000-06-02	2001-10-23	Medinox, Inc.	Protected forms of a combination of pharmacologically active agents and uses therefor
IL153303A0 (en)	2000-06-13	2003-07-06	Wyeth Corp	Analgesic and anti-inflammatory compositions conaining cox-2 inhibitors

2001
- 2001-06-13 IL IL15330301A patent/IL153303A0/xx unknown
- 2001-06-13 DK DK01946309.0T patent/DK1296665T3/da active
- 2001-06-13 ES ES01946309T patent/ES2365387T3/es not_active Expired - Lifetime
- 2001-06-13 CA CA2411960A patent/CA2411960C/en not_active Expired - Lifetime
- 2001-06-13 AT AT01946309T patent/ATE511844T1/de active
- 2001-06-13 MX MXPA02012344A patent/MXPA02012344A/es active IP Right Grant
- 2001-06-13 WO PCT/US2001/018990 patent/WO2001095898A1/en not_active Ceased
- 2001-06-13 EA EA200802070A patent/EA200802070A1/ru unknown
- 2001-06-13 PT PT01946309T patent/PT1296665E/pt unknown
- 2001-06-13 US US10/297,897 patent/US6924303B2/en not_active Expired - Lifetime
- 2001-06-13 AU AU6837701A patent/AU6837701A/xx active Pending
- 2001-06-13 BR BR0111767-0A patent/BR0111767A/pt not_active Application Discontinuation
- 2001-06-13 KR KR1020027016906A patent/KR20030019422A/ko not_active Ceased
- 2001-06-13 AU AU2001268377A patent/AU2001268377B2/en not_active Expired
- 2001-06-13 PL PL360469A patent/PL206268B1/pl unknown
- 2001-06-13 HU HU0301348A patent/HU229440B1/hu unknown
- 2001-06-13 JP JP2002510077A patent/JP5579958B2/ja not_active Expired - Lifetime
- 2001-06-13 NZ NZ522957A patent/NZ522957A/en not_active IP Right Cessation
- 2001-06-13 RU RU2003100874/15A patent/RU2003100874A/ru not_active Application Discontinuation
- 2001-06-13 CN CN01813180A patent/CN100588395C/zh not_active Expired - Lifetime
- 2001-06-13 EP EP01946309A patent/EP1296665B1/en not_active Expired - Lifetime
- 2001-06-13 EA EA200300692A patent/EA011309B1/ru not_active IP Right Cessation
2002
- 2002-12-05 IL IL153303A patent/IL153303A/en active IP Right Grant
- 2002-12-09 ZA ZA200209944A patent/ZA200209944B/xx unknown
- 2002-12-12 NO NO20025983A patent/NO331092B1/no not_active IP Right Cessation
2004
- 2004-12-13 US US11/012,021 patent/US7754753B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN100588395C (zh)	2010-02-10
NO331092B1 (no)	2011-10-03
HUP0301348A2 (hu)	2003-08-28
US6924303B2 (en)	2005-08-02
NZ522957A (en)	2004-03-26
KR20030019422A (ko)	2003-03-06
AU2001268377B2 (en)	2005-07-07
RU2003100874A (ru)	2004-06-27
AU6837701A (en)	2001-12-24
JP5579958B2 (ja)	2014-08-27
US20030216461A1 (en)	2003-11-20
IL153303A (en)	2010-11-30
EP1296665A4 (en)	2005-07-27
BR0111767A (pt)	2003-07-08
EA200300692A1 (ru)	2003-12-25
EP1296665A1 (en)	2003-04-02
HUP0301348A3 (en)	2005-05-30
NO20025983D0 (no)	2002-12-12
ZA200209944B (en)	2003-10-08
MXPA02012344A (es)	2004-02-26
EA011309B1 (ru)	2009-02-27
PL360469A1 (en)	2004-09-06
ATE511844T1 (de)	2011-06-15
JP2004503497A (ja)	2004-02-05
CN1443067A (zh)	2003-09-17
ES2365387T3 (es)	2011-10-03
EP1296665B1 (en)	2011-06-08
IL153303A0 (en)	2003-07-06
PT1296665E (pt)	2011-07-05
CA2411960A1 (en)	2001-12-20
HU229440B1 (en)	2013-12-30
EA200802070A1 (ru)	2009-06-30
HK1059378A1 (zh)	2004-07-02
DK1296665T3 (da)	2011-07-18
US20050090538A1 (en)	2005-04-28
CA2411960C (en)	2010-10-12
PL206268B1 (pl)	2010-07-30
US7754753B2 (en)	2010-07-13
WO2001095898A1 (en)	2001-12-20

Legal Events

Date	Code	Title	Description
2021-07-12	MK1K	Patent expired

Publication	Publication Date	Title
CY1108823T1 (el)	2014-04-09	Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3
DK1509232T3 (da)	2009-02-23	Kombination af en NMDA-antagonist og acetylcholin-esterase inhibitorer til behandling af Alzheimers sygdom
BR9907300A (pt)	2000-10-24	Inibidores do fator xa oxoaza-heterociclila substituìdos
ATE303178T1 (de)	2005-09-15	Acc-hemmer
BRPI0409068A (pt)	2006-03-28	composições farmacêuticas para inibidores de protease viral de hepatite c.
HUP0301660A2 (hu)	2003-09-29	Neutrális endropeptidáz inhibitor (NEPI) vegyületek alkalmazása férfi szexuális mżködési zavar kezelésére és az azokat tartalmazó gyógyszerkészítmények
EA200500312A1 (ru)	2005-08-25	Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
EE200300168A (et)	2003-06-16	Tripeptidüülpeptidaasi inhibiitorid, nende valmistamine ja kasutamine ravimina ning neid sisaldav farmatseutiline kompositsioon
DK1678162T3 (da)	2010-08-02	P-glycoprotein-inhibitor, fremgangsmåde til fremstilling heraf og farmaceutisk sammensætning omfattende denne
UA91204C2 (ru)	2010-07-12	Композиция для преодоления опосредствованной бета-лактамазой резистентности к антибиотикам с использованием ингибитора бета-лактамазы, предназначенная для инъекции
NO20025983L (no)	2003-02-10	Smertestillende og antiinflammatoriske sammensetninger som inneholder COX-2hemmere
CY1107473T1 (el)	2012-12-19	Ενα παραγωγο pyridine-n-oxide, και διαδικασια για τη μετατροπη του σε αποτελεσματικες φαρμακευτικες συνθεσεις
BR0306928A (pt)	2004-11-09	Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace)
BR0213181A (pt)	2004-08-31	Combinações de inibidor de cox-2
ATE193526T1 (de)	2000-06-15	Alkylierte styrole als prodrugs zu cox-2- inhibitoren
NO983511D0 (no)	1998-07-30	Difenylstilbener som pro-legemidler for COX-2-inhibitorer
MXPA02010828A (es)	2004-07-16	Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
HUP0303341A2 (hu)	2004-01-28	Monoamin-felvétel inhibitora és ezt tartalmazó gyógyszerkészítmények
EP1627644A4 (en)	2012-01-18	PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION WITH AN NON-TEROIDAL INFLAMMATORY MEDICAMENT AND AN INTERLEUKIN 1A PRODUCTION INHIBITOR
PT1250125E (pt)	2004-04-30	Composicoes farmaceuticas contendo terbinafina
EA200601015A1 (ru)	2006-10-27	Пероральные композиции дезоксипеганина и их применение
ATE270551T1 (de)	2004-07-15	Kombinationspräparat aus 2-methylthiazolidin-2,4- dicarbonsäure und paracetamol
AU2001244999A1 (en)	2001-10-23	Naphthamide neurokinin antagonists for use as medicaments
DK1648413T3 (da)	2010-01-11	Farmaceutiske præparater af kortvirkende sedativt sövndyssende middel
WO2001072735A3 (en)	2002-03-28	Benzopyranes useful as tnf alpha inhibitors